|
17
|
99
|
7m9rA |
Hiv-1 protease wt (nl4-3) in complex with lr4-44 |
|
18
|
99
|
7ldzA |
Hiv-1 protease wt (nl4-3) in complex with grl-98065 |
|
19
|
99
|
7m9qA |
Hiv-1 protease wt (nl4-3) in complex with lr4-33 |
|
18
|
99
|
7m9nA |
Hiv-1 protease (i84v) in complex with lr3-68 |
|
19
|
99
|
7m9zA |
Hiv-1 protease (i84v) in complex with tmc-126 |
|
18
|
99
|
7mafA |
Hiv-1 protease (i84v) in complex with pu2 (lr2-79) |
|
18
|
99
|
7m9iA |
Hiv-1 protease (i84v) in complex with lr2-26 |
|
18
|
99
|
7m9gA |
Hiv-1 protease (i84v) in complex with lr2-18 |
|
18
|
99
|
7ma2A |
Hiv-1 protease (i84v) in complex with a darunavir derivative |
|
18
|
99
|
7le2A |
Hiv-1 protease wt (nl4-3) in complex with umass4 |
|
18
|
99
|
7m9kA |
Hiv-1 protease wt (nl4-3) in complex with lr3-48 |
|
18
|
99
|
7m9pA |
Hiv-1 protease (i84v) in complex with lr3-55 |
|
17
|
99
|
7m9hA |
Hiv-1 protease (i84v) in complex with lr2-20 |
|
18
|
99
|
7ma0A |
Hiv-1 protease (i84v) in complex with lr2-91 |
|
17
|
99
|
7madA |
Hiv-1 protease (i84v) in complex with pd5 (lr4-22) |
|
17
|
99
|
7macA |
Hiv-1 protease (i84v) in complex with pd4 (lr4-23) |
|
18
|
99
|
7magA |
Hiv-1 protease (i84v) in complex with pu3 (lr3-69) |
|
17
|
99
|
7maoA |
Hiv-1 protease (i84v) in complex with pu10 (lr4-07) |
|
17
|
99
|
7maeA |
Hiv-1 protease (i84v) in complex with pu1 (lr3-46) |
|
18
|
99
|
7ldyA |
Hiv-1 protease wt (nl4-3) in complex with tmc-126 |
|
17
|
99
|
7majA |
Hiv-1 protease (i84v) in complex with pu6 (lr3-66) |
|
18
|
99
|
7manA |
Hiv-1 protease (i84v) in complex with pu9 (lr2-80) |
|
18
|
99
|
7m9mA |
Hiv-1 protease wt (nl4-3) in complex with lr3-55 |
|
18
|
99
|
7ma1A |
Hiv-1 protease (i84v) in complex with grl-98065 |
|
17
|
99
|
7makA |
Hiv-1 protease (i84v) in complex with pu7 (lr3-67) |
|
18
|
99
|
7maiA |
Hiv-1 protease (i84v) in complex with pu5 (lr4-47) |
|
17
|
99
|
7le1A |
Hiv-1 protease wt (nl4-3) in complex with umass2 |
|
18
|
99
|
8fuiA |
Hiv-1 wild type protease with grl-02519a, with n-(2,5-dimethylphenyl)-4-(pyridin-3-yl)pyrimidin-2-amine as p2-p3 group |
|
18
|
99
|
8fujA |
Hiv-1 wild type protease with grl-03419a, with n-(2,5-dimethylphenyl)-4-(pyridin-3-yl)pyrimidin-2-amine as p2-p3 group and 3,5-difluorophenylmethyl as the p1 group |
|
18
|
99
|
8esxA |
Hiv protease in complex with benzoxaborolone analog of darunavir |
|
18
|
99
|
8esyA |
D30n mutant hiv protease in complex with benzoxaborolone analog of darunavir |
|
18
|
99
|
8f0fA |
Hiv-1 wild type protease with grl-110-19a, a chloroacetamide derivative based on darunavir as p2' group |
|
163
|
477
|
8e5wA |
Crystal structure of dehydroalanine hip1 |
|
18
|
99
|
7ma6A |
Hiv-1 protease (i84v) in complex with umass5 |
|
17
|
99
|
7masA |
Drug resistant hiv-1 protease (l10f, m46i, i50v, f53l, l63p, g73s) in complex with drv |
|
18
|
99
|
7maaA |
Hiv-1 protease (i84v) in complex with umass10 |
|
18
|
99
|
7ma8A |
Hiv-1 protease (i84v) in complex with umass8 |
|
18
|
99
|
7ma4A |
Hiv-1 protease (i84v) in complex with umass3 |
|
18
|
99
|
7maqA |
Drug resistant hiv-1 protease (l10f, v32i, l33f, k45i, a71v, v82i, i84v) in complex with drv |
|
17
|
99
|
7marA |
Drug resistant hiv-1 protease (l10f, m46i, i47v, i50v, f53l, l63p, i72v, g73s, v82i, i85v) in complex with drv |
|
18
|
99
|
7ma7A |
Hiv-1 protease (i84v) in complex with umass7 |
|
18
|
99
|
7ma5A |
Hiv-1 protease (i84v) in complex with umass4 |
|
18
|
99
|
7ma3A |
Hiv-1 protease (i84v) in complex with umass2 |
|
18
|
99
|
7ma9A |
Hiv-1 protease (i84v) in complex with umass9 |
|
18
|
99
|
7mapA |
Drug resistant hiv-1 protease (l10i, v32i, l33f, k45i, m46i, i50v, a71v, v82i, i84v) in complex with drv |
|
18
|
99
|
7wcqA |
Crystal structure of hiv-1 protease in complex with lactam derivative 1 |
|
16
|
99
|
7wbsA |
Crystal structure of hiv-1 protease in complex with lactam derivative 2 |
|
15
|
99
|
7yf6A |
Crystal structure of hiv-1 protease in complex with macrocyclic peptide |
|
1
|
7
|
7yf6C |
Crystal structure of hiv-1 protease in complex with macrocyclic peptide |
|
22
|
99
|
8dchA |
Crystal structure of a highly resistant hiv-1 protease clinical isolate pr10x with grl-0519 (tris-tetrahydrofuran as p2 ligand) |
